医学
单克隆抗体
美罗华
临床试验
抗体
免疫学
内科学
淋巴瘤
肿瘤科
单克隆抗体治疗
作者
Surjit Singh,Nitish K. Kumar,Pradeep Dwiwedi,Jaykaran Charan,Rimple Jeet Kaur,Preeti Sidhu,Vinay Kumar Chugh
标识
DOI:10.2174/1574884712666170809124728
摘要
With the advent of fully human MAbs, the efficacy and safety have improved in the treatment of various cardiovascular, cancer, respiratory, hematology, autoimmune diseases and infections. The introduction of biosimilars will increase the affordability and utilization of MAbs in the treatment of various diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI